A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)

NCT01076075 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

427

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin phosphate
DRUG: Comparator: placebo to pioglitazone
DRUG: Comparator: placebo to Sitagliptin
DRUG: Comparator: pioglitazone
DRUG: Glimepiride or gliclazide
DRUG: Metformin
DRUG: Pioglitazone rescue therapy

Sponsor

Merck Sharp & Dohme LLC